5955-39-5,MFCD14735619
Catalog No.:AA00IAHO

5955-39-5 | 3-Phenyl-1,4-diazaspiro[4.4]non-3-ene-2-thione

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
>97%
1 week  
$299.00   $209.00
- +
5mg
>97%
1 week  
$319.00   $223.00
- +
10mg
>97%
1 week  
$358.00   $250.00
- +
500mg
>97%
1 week  
$586.00   $411.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00IAHO
Chemical Name:
3-Phenyl-1,4-diazaspiro[4.4]non-3-ene-2-thione
CAS Number:
5955-39-5
Molecular Formula:
C13H14N2S
Molecular Weight:
230.3287
MDL Number:
MFCD14735619
SMILES:
S=C1NC2(N=C1c1ccccc1)CCCC2
Properties
Computed Properties
 
Complexity:
323  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2.5  

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Historical Records
Tags:5955-39-5 Molecular Formula|5955-39-5 MDL|5955-39-5 SMILES|5955-39-5 3-Phenyl-1,4-diazaspiro[4.4]non-3-ene-2-thione
Catalog No.: AA00IAHO
5955-39-5,MFCD14735619
5955-39-5 | 3-Phenyl-1,4-diazaspiro[4.4]non-3-ene-2-thione
Pack Size: 1mg
Purity: >97%
1 week
$299.00 $209.00
Pack Size: 5mg
Purity: >97%
1 week
$319.00 $223.00
Pack Size: 10mg
Purity: >97%
1 week
$358.00 $250.00
Pack Size: 500mg
Purity: >97%
1 week
$586.00 $411.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00IAHO
Chemical Name: 3-Phenyl-1,4-diazaspiro[4.4]non-3-ene-2-thione
CAS Number: 5955-39-5
Molecular Formula: C13H14N2S
Molecular Weight: 230.3287
MDL Number: MFCD14735619
SMILES: S=C1NC2(N=C1c1ccccc1)CCCC2
Properties
Complexity: 323  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 16  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2.5  
Literature fold

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Building Blocks More >
604798-81-4
604798-81-4
Trans-1-Benzyl-4-methyl-3-pyrrolidinecarboxylic acid
AA00IAMP | MFCD11845474
61310-31-4
61310-31-4
2-(3-Pyridinyl)-4-pyrimidinamine
AA00IARF | MFCD03001257
620595-02-0
620595-02-0
4,4,5,5-Tetramethyl-2-[4-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)phenyl]-1,3,2-dioxaborolane
AA00IAW1 | MFCD22495442
629-06-1
629-06-1
1-Chloroheptane
AA00IB0Y | MFCD00001021
63609-01-8
63609-01-8
2-(3,4-Dimethoxyphenyl)ethylisocyanide
AA00IB5Y | MFCD02664626
64747-82-6
64747-82-6
1-(3-Chloropropyl)-4-fluorobenzene
AA00IBBQ | MFCD09744312
66246-88-6
66246-88-6
1H-1,2,4-Triazole, 1-[2-(2,4-dichlorophenyl)pentyl]-
AA00IBI4 | MFCD00078737
67915-31-5
67915-31-5
Terconazole
AA00IBOT | MFCD05662369
6921-64-8
6921-64-8
1-(2-Hydroxy-4-methylphenyl)ethan-1-one
AA00IBU6 | MFCD00100559
70717-76-9
70717-76-9
(R)-tert-Butyl (1-amino-3-methyl-1-oxobutan-2-yl)carbamate
AA00IC0N | MFCD09027060
Submit
© 2017 AA BLOCKS, INC. All rights reserved.